Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus

被引：3

作者：

Finucane, K. A. ^{[1
]}

Archer, C. B. ^{[1
]}

机构：

[1] Univ Hosp Bristol NHS Fdn Trust, Bristol Dermatol Ctr, Bristol, Avon, England

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2010年 / 35卷 / 01期

关键词：

D O I：

10.1111/j.1365-2230.2009.03526.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

This is the sixth in a series of CPD articles aimed at reviewing the recent general medical literature relating to topics that may be of interest to dermatologists. In this issue the new classes of anti-retroviral drugs will be described in the context of the replication cycle of human immunodeficiency virus (HIV). The regimens of drug treatments and the more common side-effects including HIV-lipodystrophy syndrome will be discussed along with the recommendations for testing of people for HIV from new guidelines.

引用

页码：107 / 109

页数：3

共 50 条

[31] The potential impact of highly active antiretroviral therapy on the treatment and epidemiology of ranula in human immunodeficiency virus-positive patients
Syebele, Kabunda
Munzhelele, Thifhelimbilu I.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2013, 116 (01): : E32 - E36
[32] Pediatric Human Immunodeficiency Virus infection and cancer in the Highly Active Antiretroviral Treatment (HAART) era
Chiappini, Elena
Berti, Elettra
Gianesin, Ketty
Petrara, Maria Raffaella
Galli, Luisa
Giaquinto, Carlo
de Martino, Maurizio
De Rossi, Anita
CANCER LETTERS, 2014, 347 (01) : 38 - 45
[33] Echocardiographic abnormalities in children and adolescents living with human immunodeficiency virus on highly active antiretroviral treatment
Wubayehu, Tewolde
Abebe, Workeabeba
Tefera, Endale
CARDIOVASCULAR JOURNAL OF AFRICA, 2020, 31 (05) : 236 - 240
[34] Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy
Torre, D
Tambini, R
Cadario, F
Barbarini, G
Moroni, M
Basilico, C
CLINICAL INFECTIOUS DISEASES, 2001, 33 (09) : 1579 - 1585
[35] Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients
Duro, M.
Rebelo, I.
Barreira, S.
Sarmento-Castro, R.
Medeiros, R.
Almeida, C.
INTERNATIONAL JOURNAL OF STD & AIDS, 2015, 26 (11) : 796 - 802
[36] Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals
Tacconelli, E
de Gaetano, K
Cauda, R
Ortona, L
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) : 901 - 902
[37] Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy
Shekatkar, Madhura
Kheur, Supriya
Gupta, Archana A.
Arora, Aavishi
Raj, A. Thirumal
Patil, Shankargouda
Khan, Samar Saeed
Desai, Ami
Carroll, William B.
Awan, Kamran Habib
DM DISEASE-A-MONTH, 2021, 67 (09):
[38] Causes of mortality among patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy
Camino, X
Iribarren, JA
Arrizabalaga, J
Rodríguez, F
von Wichmann, MA
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2001, 19 (02): : 85 - 86
[39] Harmful effect of highly active antiretroviral therapy on arterial stiffness of patients infected with human immunodeficiency virus
Lekakis, J.
Ikonomidis, I.
Palios, I.
Tsiodras, S.
Karatzis, E.
Poulakou, G.
Papadopoulos, A.
Antoniadou, A.
Giamarellou, H.
Kremastinos, D. T.
EUROPEAN HEART JOURNAL, 2008, 29 : 87 - 87
[40] Association of Highly Active Antiretroviral Therapy With Increased Arterial Stiffness in Patients Infected With Human Immunodeficiency Virus
Lekakis, John
Ikonomidis, Ignatios
Palios, John
Tsiodras, Sotirios
Karatzis, Emmanouil
Poulakou, Garyfalia
Rallidis, Loukianos
Antoniadou, Anastasia
Panagopoulos, Periklis
Papadopoulos, Antonios
Triantafyllidi, Helen
Giamarellou, Helen
Kremastinos, Dimitrios T.
AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (08) : 828 - 834

← 1 2 3 4 5 →